PJP
Invesco Pharmaceuticals ETF
1W: +0.5%
1M: -7.6%
3M: -4.9%
YTD: -2.6%
1Y: +21.1%
3Y: +40.5%
5Y: +34.0%
$101.70
-0.33 (-0.32%)
After Hours: $109.49 (+7.79, +7.66%)
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Weather
ETF-Level Metrics
AUM$299M
Holdings31
Top 10 Wt47.8%
Beta0.61
% Profitable68%
Coverage100%
Portfolio Valuation
P/E26.9
P/B3.0
P/S5.6
EV/EBITDA16.5
P/FCF27.2
PEG4.58
Profitability & Returns
Gross Margin79.7%
Net Margin20.5%
ROE16.0%
ROA6.9%
ROIC11.3%
Div Yield1.64%
Leverage & Liquidity
Debt/Equity0.45
Debt/Assets0.22
Net Debt/EBITDA0.8x
Interest Cov10.1x
Current Ratio1.52
Quick Ratio1.26
Growth (YoY)
Revenue+23.2%
Net Income+41.2%
EPS+43.0%
FCF+15.4%
EBITDA+45.2%
Rev CAGR 3Y+16.2%
Quality Scores
Piotroski F6.0
Altman Z4.79
IS Quality67.3
IS Overall57.7
IS Value48.7
Median P/E17.0
Sector Breakdown
2 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 30 | 100.0% | 9.1 |
| Financial Services | 1 | 0.0% | — |
Smart Money Overlap
5 holdings with signals| Symbol | Company | Weight % | Signals | Badge | Insider Buys | Congress | Since Signal |
|---|---|---|---|---|---|---|---|
| PFE | Pfizer Inc. | 5.53% | 4 | Bullish | 11 | 2 | +3.7% |
| JNJ | Johnson & Johnson | 5.28% | 4 | Bullish | 12 | 2 | -1.2% |
| MRK | Merck & Co., Inc. | 5.08% | 4 | Bullish | 11 | 2 | +0.5% |
| REGN | Regeneron Pharmaceuticals, Inc. | 2.89% | 4 | Bullish | 16 | 1 | -3.3% |
| BIIB | Biogen Inc. | 2.85% | 4 | Bullish | 1 | 1 | -2.3% |
Showing 31 of 31 holdings
· Page 1 of 1
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | Pfizer Inc | PFE | 5.53% | $21.6M | 789,148 | 20.2 | $156.7B | Healthcare |
| 2 | Johnson & Johnson | JNJ | 5.28% | $20.7M | 86,964 | 21.7 | $576.5B | Healthcare |
| 3 | Gilead Sciences Inc | GILD | 5.26% | $20.5M | 145,065 | 20.0 | $169.9B | Healthcare |
| 4 | Abbott Laboratories | ABT | 5.12% | $20.0M | 186,921 | 28.0 | $181.7B | Healthcare |
| 5 | Merck & Co Inc | MRK | 5.08% | $19.7M | 172,819 | 16.2 | $294.1B | Healthcare |
| 6 | Amgen Inc | AMGN | 5.00% | $19.6M | 55,940 | 24.7 | $190.4B | Healthcare |
| 7 | AbbVie Inc | ABBV | 4.94% | $19.3M | 93,754 | 88.9 | $373.3B | Healthcare |
| 8 | Eli Lilly & Co | LLY | 4.82% | $18.9M | 20,552 | 39.0 | $847.1B | Healthcare |
| 9 | Ligand Pharmaceuticals Inc | LGND | 3.38% | $13.2M | 62,762 | 32.3 | $4.1B | Healthcare |
| 10 | United Therapeutics Corp | UTHR | 3.37% | $13.2M | 25,056 | 17.7 | $23.3B | Healthcare |
| 11 | Liquidia Corp | LQDA | 3.37% | $13.2M | 353,351 | -46.5 | $3.2B | Healthcare |
| 12 | Jazz Pharmaceuticals PLC | JAZZ | 3.17% | $12.4M | 68,240 | -32.4 | $11.6B | Healthcare |
| 13 | Harmony Biosciences Holdings Inc | HRMY | 2.99% | $11.7M | 420,787 | 10.0 | $1.6B | Healthcare |
| 14 | ANI Pharmaceuticals Inc | ANIP | 2.96% | $11.6M | 154,654 | 19.6 | $1.7B | Healthcare |
| 15 | Regeneron Pharmaceuticals Inc | REGN | 2.89% | $11.3M | 15,361 | 17.3 | $78.6B | Healthcare |
| 16 | Bristol-Myers Squibb Co | BMY | 2.86% | $11.2M | 192,565 | 17.2 | $121.0B | Healthcare |
| 17 | Innoviva Inc | INVA | 2.86% | $11.2M | 506,489 | 6.3 | $1.5B | Healthcare |
| 18 | Biogen Inc | BIIB | 2.85% | $11.1M | 60,790 | 21.7 | $28.0B | Healthcare |
| 19 | Corcept Therapeutics Inc | CORT | 2.83% | $11.1M | 325,164 | 40.4 | $4.1B | Healthcare |
| 20 | Ocular Therapeutix Inc | OCUL | 2.80% | $11.0M | 1,324,622 | -6.8 | $1.8B | Healthcare |
| 21 | Supernus Pharmaceuticals Inc | SUPN | 2.78% | $10.9M | 222,552 | -75.6 | $2.9B | Healthcare |
| 22 | Travere Therapeutics Inc | TVTX | 2.72% | $10.6M | 384,132 | -50.2 | $2.6B | Healthcare |
| 23 | Tarsus Pharmaceuticals Inc | TARS | 2.70% | $10.6M | 158,138 | -43.3 | $2.9B | Healthcare |
| 24 | Prestige Consumer Healthcare Inc | PBH | 2.65% | $10.4M | 172,438 | 15.5 | $2.9B | Healthcare |
| 25 | Amneal Pharmaceuticals Inc | AMRX | 2.55% | $10.0M | 809,140 | 52.4 | $3.8B | Healthcare |
| 26 | Viatris Inc | VTRS | 2.55% | $10.0M | 738,375 | -4.4 | $15.4B | Healthcare |
| 27 | Collegium Pharmaceutical Inc | COLL | 2.44% | $9.5M | 262,608 | 16.9 | $1.1B | Healthcare |
| 28 | Amphastar Pharmaceuticals Inc | AMPH | 2.14% | $8.4M | 428,617 | 9.1 | $897M | Healthcare |
| 29 | Perrigo Co PLC | PRGO | 2.07% | $7.8M | 811,909 | -0.9 | $1.3B | Healthcare |
| 30 | Invesco Government & Agency Portfolio | AGPXX | 0.05% | $179,035 | 179,035 | — | $79.1B | Financial Services |
| 31 | OmniAb Inc | OABI | —% | — | 78,046 | -3.1 | $180M | Healthcare |